FDA Approves Pradaxa To Prevent Stroke In People With Atrial Fibrillation

Links shared publicly online about this topic.

  • 787
    total visits

FDA Approves Pradaxa To Prevent Stroke In People With Atrial Fibrillation

medicalnewstoday.com

The U.S. Food and Drug Administration approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).

View full resource at medicalnewstoday.com

Tags: Heart, Heart Disease, Arrhythmia, Atrial Fibrillation, Stroke, Thrombotic Event, FDA

  • Share

Most Recently Shared on October 20, 2010 at 7:05 pm By:

mnt_drugapprov MNT Drug Approvals

FDA Approves Pradaxa To Prevent Stroke In People With Atrial Fibrillation http://mnt.to/3Ltg #regulatory

1 year ago...

Also Shared By:

MNT Stroke News MNT Stroke News

MNT Heart News MNT Heart News

MNT Preventive Med MNT Preventive Med

Patients Taking Dabigatran (Pradaxa) Must Store It In Original Bottle And Discard Unused Medication After 30 Days

medicalnewstoday.com — “Dabigatran (brand name: Pradaxa) is an anti-clotting medication that was approved by the FDA in October 2010. It's given to patients with atrial fibrillation to help prevent stroke.It isView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 17, 2011 at 7:05 pm By:

mnt_stroke MNT Stroke News Health News

Patients Taking Dabigatran (Pradaxa) Must Store It In Original Bottle And Discard Unused Medication After 30 Days http://mnt.to/3Rhp #stroke

1 year ago...

Pradaxa primer: A guide to treatment with dabigatran etexilate - - Drug Topics

drugtopics.modernmedicine.com — “In October 2010, FDA approved dabigatran etexilate (Pradaxa, Boehringer Ingelheim), the first oral direct thrombin inhibitor for the prevention of thromboembolic stroke in patients with nonvalvular atrial fibrillation.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on January 14, 2011 at 5:38 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Pradaxa primer: A guide to treatment with dabigatran etexilate: In October 2010, FDA approved dabigatran etexila... http://bit.ly/gGxjBK

1 year ago...

Pradaxa primer: A guide to treatment with dabigatran etexilate - - Drug Topics

drugtopics.modernmedicine.com — “In October 2010, FDA approved dabigatran etexilate (Pradaxa, Boehringer Ingelheim), the first oral direct thrombin inhibitor for the prevention of thromboembolic stroke in patients with nonvalvular atrial fibrillation.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on January 14, 2011 at 5:39 am By:

Stroke_Wisdom Stroke OW OW Health

Pradaxa primer: A guide to treatment with dabigatran etexilate: In October 2010, FDA approved dabigatran etexila... http://bit.ly/eh1CT2

1 year ago...

Physicians welcome dabigatran etexilate as alternative to warfarin - - ModernMedicine

modernmedicine.com — “In a guest editorial, 2 researchers highlighted the importance of the FDA approval in October of dabigatran etexilate (Pradaxa, Boehringer Ingelheim), an oral thrombin inhibitor that provides an alternative to warfarin (Coumadin, Bristol-Myers Squibb) for long-term stroke prevention in patients with non-valvular atrial fibrillation.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on January 7, 2011 at 5:18 pm By:

Stroke_Wisdom Stroke OW OW Health

Physicians welcome dabigatran etexilate as alternative to warfarin: In a guest editorial, 2 researchers highligh... http://bit.ly/i7xsvX

1 year ago...

New era for anticoagulant therapy

news-medical.net — “In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 23, 2010 at 12:45 am By:

Stroke_News News-Medical.Net Health News

Stroke News: New era for anticoagulant therapy: In a Guest Editorial published in the new publication Clinical... http://twurl.nl/iei23e

1 year ago...

First warfarin replacement approved - - ModernMedicine

modernmedicine.com — “Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has received FDA approval for the prevention of stroke and blood clots in patients with atrial fibrillation. It is the first replacement for warfarin to win FDA approval. Warfarin was approved in 1954.View full resource at modernmedicine.com

  • View Related
  • Share

Most Recently Shared on November 12, 2010 at 8:01 am By:

Stroke_Wisdom Stroke OW OW Health

First warfarin replacement approved: Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has received FDA appro... http://bit.ly/cQB5YK

1 year ago...

FDA approves Pradaxa to help prevent stroke in people with atrial fibrillation - San Francisco SF | Examiner.com

examiner.com — “The U.S. Food and Drug Administration (FDA) this week approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patientsView full resource at examiner.com

  • View Related
  • Share

Most Recently Shared on October 25, 2010 at 3:59 am By:

sfseniorcare Liz Macera Nurse

FDA approves Pradaxa to help prevent stroke in people with atrial fibrillation http://exm.nr/aekT3f

1 year ago...

Pradaxa bests warfarin for atrial fibrillation stroke risk - USATODAY.com

usatoday.com — “The drug Pradaxa has been approved by the U.S. Food and Drug Administration to help prevent stroke in people with a type of abnormal heart rhythm called atrial fibrillation...View full resource at usatoday.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 7:17 pm By:

USATODAYhealth Maureen Linke Health News

Pradaxa bests warfarin for atrial fibrillation stroke risk http://usat.ly/9lT3Jr

1 year ago...

Therapeutics Daily

therapeuticsdaily.com — “Therapeutics DailyView full resource at therapeuticsdaily.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 5:37 pm By:

pharmalive PharmaLive Pharma and Health News

Therapeutics Daily - FDA Approves Pradaxa to Prevent Stroke in People with Atrial Fibrillation - http://tinyurl.com/2548d9g

1 year ago...

Pradaxa Approved for Atrial Fibrillation

health.yahoo.net — “WEDNESDAY, Oct. 20 (HealthDay News) -- Pradaxa (dabigatran etexilate) has been approved by the U.S. Food and Drug Administration to help prevent stroke in people with a type of abnormal heart rhythm called atrial fibrillation.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 1:40 am By:

Pradaxa Approved for Atrial Fibrillation --Doctors Lounge

doctorslounge.com — “Pradaxa Approved for Atrial Fibrillation --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 9:31 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Pradaxa Approved for Atrial Fibrillation: To prevent stroke in people with abnormal heart rhythm http://bit.ly/bJw6bg

1 year ago...

Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke - Yahoo! News

news.yahoo.com — “WEDNESDAY, Oct. 20 (HealthDay News) -- The drug Pradaxa has been approved by the U.S. Food and Drug Administration to help prevent stroke in people with a type of abnormal heart rhythm called atrial fibrillation.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 9:28 pm By:

Stroke_Wisdom Stroke OW OW Health

Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke: WEDNESDAY, Oct. 20 (HealthDay News) -- The drug ... http://yhoo.it/dvkvyx

1 year ago...

Breaking news: First warfarin replacement approved - - Drug Topics

drugtopics.modernmedicine.com — “Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has received FDA approval for the prevention of stroke and blood clots in patients with atrial fibrillation. It is the first replacement for warfarin to win FDA approval.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 6:20 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Breaking news: First warfarin replacement approved: Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) ha... http://bit.ly/cBguHi #pharma

1 year ago...

Breaking news: First warfarin replacement approved - - Drug Topics

drugtopics.modernmedicine.com — “Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has received FDA approval for the prevention of stroke and blood clots in patients with atrial fibrillation. It is the first replacement for warfarin to win FDA approval.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 6:13 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Breaking news: First warfarin replacement approved: Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has ... http://bit.ly/cM2HHF #drug

1 year ago...

Advertisement